Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc. | 2,449,183 | 2,449,183 | 0 | $213.91M | $258.14M | 39.57% | +$44.23M |
| Nanobiotix S.A.ADS(NBTX) | 5,623,816 | 5,623,816 | 0 | $130.02M | $173.61M | 26.61% | +$43.58M |
| MeiraGTx Holdings plc(MGTX) | 6,641,064 | 6,641,064 | 0 | $52.80M | $57.51M | 8.82% | +$4.72M |
| Rapport Therapeutics, Inc.(RAPP) | 1,784,517 | 1,784,517 | 0 | $54.14M | $55.84M | 8.56% | +$1.70M |
| CVRx, Inc.(CVRX) | 4,024,861 | 4,024,861 | 0 | $28.58M | $38.08M | 5.84% | +$9.50M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 1,979,173 | 1,979,173 | 0 | $22.62M | $25.85M | 3.96% | +$3.23M |
| Legend Biotech CorporationADS(LEGN) | 814,586 | 814,586 | 0 | $17.71M | $14.74M | 2.26% | -$2.97M |
| Xencor, Inc.(XNCR) | 748,062 | 748,062 | 0 | $11.45M | $9.02M | 1.38% | -$2.43M |
| PROCEPT BioRobotics Corporation(PRCT) | 357,939 | 357,939 | 0 | $11.26M | $8.95M | 1.37% | -$2.31M |
| Fate Therapeutics, Inc.(FATE) | 3,379,064 | 3,379,064 | 0 | $3.32M | $4.05M | 0.62% | +$734.6K |
| Neumora Therapeutics, Inc.(NMRA) | 1,849,445 | 1,849,445 | 0 | $3.31M | $3.61M | 0.55% | +$295.9K |
| Rallybio Corporation(RLYB) | 0 | 152,901 | +152,901 | $0 | $1.37M | 0.21% | +$1.37M |
| Vor Biopharma Inc.(VOR) | 53,732 | 53,732 | 0 | $702.8K | $958.6K | 0.15% | +$255.8K |
| Standard BioTools Inc.(LAB) | 311,967 | 311,967 | 0 | $399.3K | $286.8K | 0.04% | -$112.5K |
| Nano-X Imaging Ltd. ORD SHS | 158,852 | 83,554 | -75,298 | $444.8K | $189.7K | 0.03% | -$255.1K |
| Adicet Bio, Inc. | 22,779 | 22,779 | 0 | $191.8K | $155.1K | 0.02% | -$36.7K |
| Lyell Immunopharma, Inc.(LYEL) | 54,887 | 0 | -54,887 | $1.69M | $0 | — | -$1.69M |
| Rallybio Corporation(RLYB) | 3,636,363 | 0 | -3,636,363 | $2.49M | $0 | — | -$2.49M |